No black box warning on record for Coagadex

As of the latest FDA labeling reviewed, Coagadex (COAGULATION FACTOR X HUMAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Coagadex medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions, including anaphylaxis, are possible. Should symptoms occur, discontinue COAGADEX and administer appropriate treatment ( 5.1 ). Development of neutralizing antibodies (inhibitors) may occur. If expected plasma Factor X activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform an assay that measures Fac

No black box warning on record for Coagadex

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions, including anaphylaxis, are possible. Should symptoms occur, discontinue COAGADEX and administer appropriate treatment ( 5.1 ). Development of neutralizing antibodies (inhibitors) may occur. If expected plasma Factor X activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform an assay that measures Fac

Coagadex Black Box Warning

No black box warning on record for Coagadex

Other warnings & precautions

Coagadex Black Box Warning

No black box warning on record for Coagadex

Other warnings & precautions